Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and disability. More than 12 million people are diagnosed with COPD in the United States, and another 12 million may be undiagnosed. The condition is the fourth leading cause of death in the U.S. This presentation discusses the pathogenesis and diagnosis of COPD; reviews the findings of recent trials with evidence-based treatment options for COPD; and discusses new and evolving treatments for COPD, including PDE-4 inhibitors.
The webcast was recorded live and is being used with the permission of the presenter.
Pulmonologists and Primary Care Providers
After participating in this activity, participants should be better able to:
- Explain the pathogenesis and diagnosis of COPD
- Discuss findings of recent trials and evidence-based treatment options for COPD
- Explore new and evolving treatments, including PDE-4 inhibitors for COPD
AMA PRA Category 1 Credit(s)TM
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Association for Continuing Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Charlie Strange, MD
Professor of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charlie Strange, MD, Speaker, serves as a speaker for Talecris; consults for Talecris, CSL Behring, Uptake Medical; and conducts research for Talecris, Forest Laboratories, Pneum Rx, and Pulmonx.
Franck Rahaghi, MD, MHS, FCCP, Course Director, serves as a speaker, and consultant to Actelion, Gilead, United Therapeutics, Talecris, Baxter, CSL Behring, and Pfizer; and conducts research for Baxter.
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
National Association for Continuing Education
Actelion, Boehringer-Ingelheim, CSL Behring, Gilead Sciences, Inc., and United Therapeutics provided commercial support for this enduring activity.
To obtain credit, a score of 60% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.